Latest Posts
About This Stock
More About This Stock
Read
BIO 2017 International #1: CAR-T Therapies On Solid Tumors

Article By:
Rod Raynovich
Thursday, June 22, 2017 11:45 PM EDT
CAR-T shows great promise against blood cancers but challenges remain for solid tumors. Bellicum Pharmaceuticals, Bluebird bio, Cellectis SA, Juno Therapeutics, Kite Pharma and Poseida Therapeutics are some of the major companies engaged in CAR-T.